skip to navigation skip to content
search
  • About us
    • Who we are
    • Horizon scanning
    • Public involvement
      • Public Involvement Network Advisory Group
      • Patient group partners
      • Public partners
    • Policies & publications
    • Minutes
    • Meetings
    • Register for a meeting
    • ILAP
    • Latest update
      • SMC2555 sotrovimab (Xevudy) has been discontinued and advice removed from the SMC website.
    • Contact us
  • Medicines advice
  • How we decide
    • PACE
    • Interim acceptance decision option
    • Ultra-orphan medicines for extremely rare conditions
    • Abbreviated submissions
  • Making a submission
Pills image

Latest update

  • Home
  • /
  • About us
  • /
  • Latest update
  • /
  • Patient and Public Involvement End of Year Highlights Report 2025
26 January 2026

Patient and Public Involvement End of Year Highlights Report 2025

The SMC Public Involvement team have compiled a 2025 end of year highlights report.
View the document here: Patient and Public Involvement End of Year Highlights Report 2025

About us

  • Who we are
  • Horizon scanning
  • Public involvement
  • Policies & publications
  • Minutes
  • Meetings
  • Register for a meeting
  • ILAP
  • Latest update
    • SMC2555 sotrovimab (Xevudy) has been discontinued and advice removed from the SMC website.
  • Contact us
Back to latest updates
  • Contact us
  • Register for a meeting
  • Accessibility
  • Terms and conditions
  • Respecting your privacy
  • Freedom of information

© Scottish Medicines Consortium

  • NHS Scotland Logo